68 related articles for article (PubMed ID: 31912686)
1. Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study.
Han K; Colson-Fearon D; Liu ZA; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2024 May; 119(1):143-153. PubMed ID: 37951548
[TBL] [Abstract][Full Text] [Related]
2. Nodal staging in high and high-intermediate risk endometrial cancer surgery: Which role in the molecular classification era?
Massobrio R; Novara L; Mancarella M; Pace L; Giorgi M; Pascotto M; Campigotto B; Fuso L; Sgro LG; Bounous VE; Ferrero A
J Gynecol Obstet Hum Reprod; 2024 Apr; 53(7):102787. PubMed ID: 38626819
[TBL] [Abstract][Full Text] [Related]
3. A Rare Case Report of Dedifferentiated Endometrioid Carcinoma.
Kani V; A S; P J; Menon D
Cureus; 2024 Mar; 16(3):e56329. PubMed ID: 38628996
[TBL] [Abstract][Full Text] [Related]
4. The risks and trends of cardiac-specific mortality associated with chemotherapy or radiotherapy in a large cohort of non-elderly patients with non-small cell lung cancer.
Jiang KT; Huang DZ
Transl Cancer Res; 2021 Feb; 10(2):842-853. PubMed ID: 35116414
[TBL] [Abstract][Full Text] [Related]
5. Determinants of Sensitivity to Radiotherapy in Endometrial Cancer.
Sorolla MA; Parisi E; Sorolla A
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32679719
[TBL] [Abstract][Full Text] [Related]
6. Low-dose adjuvant vaginal cylinder brachytherapy for early-stage non-endometrioid endometrial cancer: recurrence risk and survival outcomes.
Smart A; Buscariollo D; Alban G; Buzurovic I; Cheng T; Pretz J; Krechmer B; King M; Lee L
Int J Gynecol Cancer; 2020 Dec; 30(12):1908-1914. PubMed ID: 32655012
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Early Stage High-Risk Endometrioid-Type Endometrial Cancer and Patterns of Disease Relapse: A Retrospective Analysis.
Song J; Le T; Hopkins L; Fung-Kee-Fung M; Jooya A; Lupe K; Gaudet M; Samant R
Adv Radiat Oncol; 2020; 5(5):910-919. PubMed ID: 33083653
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 Trial.
Post CCB; de Boer SM; Powell ME; Mileshkin L; Katsaros D; Bessette P; Haie-Meder C; Ottevanger NPB; Ledermann JA; Khaw P; D'Amico R; Fyles A; Baron MH; Kitchener HC; Nijman HW; Lutgens LCHW; Brooks S; Jürgenliemk-Schulz IM; Feeney A; Goss G; Fossati R; Ghatage P; Leary A; Do V; Lissoni AA; McCormack M; Nout RA; Verhoeven-Adema KW; Smit VTHBM; Putter H; Creutzberg CL
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(4):975-986. PubMed ID: 33129910
[TBL] [Abstract][Full Text] [Related]
9. Management of stage II endometrial cancer and subsequent oncologic outcomes: a National Cancer Database study.
Vetter MH; Bixel K; Felix AS
J Gynecol Oncol; 2020 Nov; 31(6):e84. PubMed ID: 33078593
[TBL] [Abstract][Full Text] [Related]
10. Role of adjuvant therapy in stage IIIC2 endometrial cancer.
Bogani G; Cappuccio S; Casarin J; Narasimhulu DMM; Cilby WA; Glaser GE; Weaver AL; McGree ME; Keeney GL; Weroha J; Petersen IA; Mariani A
Int J Gynecol Cancer; 2020 Aug; 30(8):1169-1176. PubMed ID: 32646864
[TBL] [Abstract][Full Text] [Related]
11. Impact of vaginal brachytherapy on survival in stage I endometrioid endometrial carcinoma.
AlHilli M; Amarnath S; Elson P; Rybicki L; Dowdy S
Int J Gynecol Cancer; 2020 Jun; 30(6):789-796. PubMed ID: 32184268
[TBL] [Abstract][Full Text] [Related]
12. Utilization Trend and Comparison of Different Radiotherapy Modes for Patients with Early-Stage High-Intermediate-Risk Endometrial Cancer: A Real-World, Multi-Institutional Study.
Ren K; Zou L; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Sun S; Wang W; Hu K; Zhang F; Hou X; Wei L
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291913
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors and Prognosis of Early Recurrence in Stage I-II Endometrial Cancer: A Large-Scale, Multi-Center, and Retrospective Study.
Dou Y; Song K; Fu Y; Shen Y; Zhang C; Yao S; Xu C; Xia M; Lou G; Liu J; Lin B; Wang J; Zhao W; Zhang J; Cheng W; Guo H; Guo R; Xue F; Wang X; Han L; Zhao X; Li X; Zhang P; Zhao J; Ma J; Li W; Yang X; Wang Z; Liu J; Fang Y; Li K; Chen G; Sun C; Cheng X; Jiang J; Wang B; Luo D; Kong B;
Front Med (Lausanne); 2022; 9():808037. PubMed ID: 35492356
[TBL] [Abstract][Full Text] [Related]
14. Recurrent patterns after postoperative radiotherapy for early stage endometrial cancer: A competing risk analysis model.
Ren K; Wang W; Sun S; Hou X; Hu K; Zhang F
Cancer Med; 2022 Jan; 11(1):257-267. PubMed ID: 34779587
[TBL] [Abstract][Full Text] [Related]
15. Treatment optimization of pelvic external beam radiation and/or vaginal brachytherapy for patients with stage I to II high-risk Endometrioid adenocarcinoma: a retrospective multi-institutional analysis.
Wang W; Zou L; Wang T; Liu Z; He J; Sun X; Zhong W; Zhao F; Li X; Li S; Zhu H; Ma Z; Sun S; Jin M; Zhang F; Hou X; Wei L; Hu K
BMC Cancer; 2021 Jul; 21(1):774. PubMed ID: 34217240
[TBL] [Abstract][Full Text] [Related]
16. Vaginal cuff brachytherapy: do we need to treat to more than a two-centimeter active length?
Jensen GL; Barry PN; Eldredge-Hindy H; Silva SR; Todd SL; Hammonds KP; Zimmerman WR; Metzinger DS; El-Ghamry MN
J Contemp Brachytherapy; 2021 Jun; 13(3):294-301. PubMed ID: 34122569
[TBL] [Abstract][Full Text] [Related]
17. Real-World Evaluation of Modern Adjuvant Radiotherapy in Women with Stage IB Endometrial Cancer.
Chen JL; Huang CY; Huang YS; Hsu CY; Lan KH; Shih IL; Cheng WF; Chen CA; Sheu BC; Kuo SH
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33803915
[TBL] [Abstract][Full Text] [Related]
18. Survival benefit of radiation in high-risk, early-stage endometrioid carcinoma.
Xiang M; Kidd EA
J Gynecol Oncol; 2020 Jul; 31(4):e39. PubMed ID: 31912686
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
